Athletes were the first to optimize performance. Now they’re turning it into billion-dollar brands, and shaping the $4.5T wellness market.

They have always been the early adopters.

For decades, they’ve trained with full-stack health teams:

🔬 Precision diagnostics

🧬 Real-time biometrics

🥗 Personalized nutrition

🧠 Neurofeedback and recovery protocols

What’s now trending was standard protocol for them a decade ago.

But here’s what’s changed:

They’re no longer just users.

They’re founders, investors, and early-stage market makers backing the next generation of consumer health and performance brands.

Athletes are the new R&D labs.
Testing what works before the market catches on.

What do athletes know, and why are they backing these brands?

Cristiano Ronaldo → WHOOP & Bioniq

He’s betting on real-time data as the new layer of health intelligence

WHOOP delivers HRV-based recovery insights that guide daily performance. Bioniq’s biomarker-driven supplements close the loop between diagnostics and intervention.

Signal: Continuous health inputs will replace static checkups. Wellness becomes dynamic

Taylor Fritz → Eight Sleep

He sees sleep as the ultimate performance unlock.

Eight Sleep optimizes deep sleep and HRV using real-time biometric feedback and temperature control, critical for recovery and mental clarity.

Signal: Sleep tech will become the anchor of every health stack.

LeBron James → Hyperice & Tonal

He’s betting on recovery and strength as lifelong health strategies.

Hyperice supports injury prevention and muscle longevity through percussive and cryotherapy tools. Tonal delivers AI-guided resistance training for sustainable strength.

Signal: Longevity will be built through mobility and muscular resilience.

David Beckham → IM8Health

He’s co-building consumer longevity from the inside out.

IM8 blends NASA-level R&D with clinical-grade diagnostics to create accessible, precision health products for proactive aging.

Signal: Wellness is becoming more clinical, without feeling clinical.

Maria Sharapova → Aman & Therabody

She’s turning recovery into a ritual, not just a tool.

At Aman retreats and through Therabody tech, she’s championing breathwork, muscle repair, and nervous system resets as daily longevity habits.

Signal: The next wellness stack blends science with sensory experience.

Roger Federer → On Running

He’s designing for movement across a lifetime.

As co-owner, Federer’s guiding On toward footwear that enhances biomechanics, prevents injury, and sustains performance into post-athletic life.

Signal: Performance wear is shifting from speed → durability → longevity.

Serena Williams → Serena Ventures

She’s backing the underfunded future of health: femtech, wellness, and biotech.

Her portfolio reflects a bet on overlooked founders solving critical needs in hormone health, diagnostics, and recovery.

Signal: The wellness boom will be female-led and medically integrated.

Rafael Nadal → Technogym

He’s focused on smart strength for long-term mobility.

Technogym’s intelligent equipment supports rehab, flexibility, and functional power, essential for performance past peak years.

Signal: Rehab and strength training will converge into everyday wellness.

Eliud Kipchoge → Abbott Libre Sense | Lingo

He’s using glucose tracking to fine-tune performance in real time.

By tracking metabolic response mid-race, Kipchoge shows how real-time fuel monitoring drives precision endurance.

Signal: Metabolic optimization will become mainstream for all high-performers.

Diogo Dalot → Bioniq

He’s making a high-conviction bet on personalized performance nutrition.

Dalot sees biomarker-driven supplementation as foundational to recovery and injury prevention.

Signal: Personalized protocols will replace one-size-fits-all vitamins.

Austin Krajicek → Alphabeats

He’s treating cognitive recovery like physical training.

Alphabeats uses EEG neurofeedback to sharpen focus, enhance recovery, and improve stress resilience.

Signal: Brain performance will become a daily training category, just like physical strength.

💡 The Pattern

Athletes aren't backing trends.

They’re betting on what they already know works, and what the broader wellness market hasn't fully caught up to yet.

They see the gap between traditional health and actual performance.
And they’re building the bridge.

They bring what the wellness industry needs most: credibility, visibility, and urgency.

They were the first to need this tech, and now they’re turning sports science into everyday tools for recovery, longevity, and performance.

So why do we trust athletes more than doctors?

Because they have what the system doesn’t:

Skin in the game. Real-time data. And results we can see.

We’re not following them for expertise.

We’re following them because they live what they preach….and it works.

What does that say about where wellness is headed?

Aging isn’t what it used to be. It’s no longer just about adding years to life but ensuring those years are vibrant, and energetic. At the forefront of this transformation are remarkable women whose latest ventures and achievements are pushing the boundaries of what’s possible in longevity science.

From AI-powered diagnostics to gene therapy breakthroughs, these women are proving that the future of aging is not just about science, it’s about redefining what it means to thrive at every stage of life.

Meet the Women Shaping the Future of Longevity

Joanna Bensz

CEO, Longevity Center

Joanna Bensz is redefining healthcare by integrating advanced diagnostics and epigenetics into Longevity Centers across Europe, showcasing how precise healthcare can enhance both lifespan and healthspan.

Joanna's vision combines advanced diagnostics with holistic health strategies, empowering people to take charge of their health, detect issues early, and optimize their well-being for the long run. Her commitment to international collaboration is driving global progress in aging research, shaping the future of longevity.

Latest News & Milestones:

• The Longevity Center, expanded to Zurich, opening a state-of-the-art center with continuous biomarker monitoring, diagnostics, and personalized health programs.

• Launched the Brain & Memory Lab in collaboration with neurologist Dr. Stanisław Szlufik, pioneering cognitive-function optimization protocols for prevention and neurodegenerative conditions management

• Hosted the Buck Institute Clinics Roundtable, setting global standards in longevity for longevity clinics.

Celine Halioua

Founder & CEO, Loyal

Celine is pioneering longevity drugs for dogs! Through Loyal, she’s developing FDA-approved longevity drugs for dogs, that could eventually translate to humans.

By extending healthy lifespan in dogs, Celine’s work helps fast-track discoveries that could one day slow aging in humans! Her research isn’t just about dogs; it’s paving the way for science-backed longevity solutions that could directly impact our own well-being.

Latest News & Milestones:

• Loyal’s drug candidate LOY-002 cleared a major FDA milestone, becoming the second approved longevity therapy for dogs!, bringing canine longevity closer to market.

• Loyal raised $22million in new funding.

• Loyal Launched STAY study, enrolling 1,000 senior dogs to evaluate the impact of LOY-002 on healthy lifespan.

Elizabeth Parrish

CEO, BioViva

Liz isn’t just advocating longevity; she's living proof. As the first person to undergo experimental gene therapy aimed at cellular rejuvenation, she’s testing the limits of regenerative medicine at BioViva.

Her fearless approach to self-experimentation and advocacy for genetic solutions is accelerating breakthroughs that could one day help us stay healthier for longer.

Latest News & Milestones:

• Elizabeth Parrish, CEO of BioViva, will be speaking at the Longevity Summit Dublin 2025

• Early trials of BioViva’s telomerase + Klotho gene therapies showed promising cognitive improvements in dementia patients.

• Their CMV vector increased mouse lifespans by 41.4%, sparking hope for future therapies against Alzheimer’s and muscle loss.

• BioViva successfully raised Series A funding, showing wider acceptance to advance gene-therapy research.

Kayla Barnes

CEO, LYV Wellness & Co-Founder, The Health Optimization Fund

Kayla Barnes is proof that longevity isn’t just a science, it’s a lifestyle. As the owner of LYV Wellness, and a Female Longevity Community, Kayla empowers women, through practical, data-driven longevity programs. She also hosts the Longevity Optimization Podcast, where she shares actionable insights and expert discussions.

Kayla makes longevity accessible and achievable. With a focus on women's health and longevity optimization, she translates complex science into actionable strategies.

Latest News & Milestones:

• LYV Wellness introduced advanced clinical programs, including multi-omics profiling and exosome injections aimed at reducing cellular senescence and optimizing real-time protocols.

• She published a comprehensive female longevity data set and created a Female Longevity Membership, reaching over 300,000 women worldwide.

• Started the Longevity Optimization Podcast, featuring discussions with top experts from around the world.

Dr. Amy B. Killen

Longevity & Regenerative Medicine Physician, Co-founder at Humanaut Health

Amy is revolutionizing regenerative medicine, specializing in longevity-based aesthetics, sexual health, and hormone optimization. She’s known for her work in stem cell therapies and platelet-rich plasma (PRP) treatments.

She bridges the gap between cutting-edge regenerative therapies and everyday well-being, proving that true longevity is about thriving with energy, vitality, and confidence.

Latest News & Milestones:

• Humanaut Health raised $8.7 million in seed funding to expand personalized longevity clinics, making high-end regenerative therapies more accessible.

• Amy launched the Human Optimization Project (HOP) Box, a doctor-formulated supplement kit designed to enhance women’s longevity.

• She is speaking at the Longevity Docs Hormones & Longevity Mastermind event in New York City on March 29th, 2025

Nikolina Lauc

CEO, GlycanAge

Nikolina is at the forefront of glycobiology, pioneering ways to measure biological age through glycan-based biomarkers. Her company, GlycanAge, provides personalized health insights through simple at-home testing.

Nikolina Lauc turns lab research into practical tools, helping you measure and improve your biological age with real data, so you can take control of your health and aging journey.

Latest News & Milestones:

• GlycanAge raised $4.2 million in seed funding, accelerating global expansion of its glycan-based diagnostic platform.

• In 2023, Nikolina, was recognized as the Entrepreneur of the Year in Croatia

Dr. Casey Means

Co-Founder, Levels

Casey is a pioneer in metabolic health and co-founder of Levels, a platform that uses real-time glucose monitoring and AI-driven insights to empower healthier lives.

Dr. Casey helps you understand how stable blood sugar and balanced energy aren’t just health trends, they’re the foundation for a longer, healthier life. Her work shows that optimizing your metabolism can sharpen your mind, boost daily energy, and reduce long-term disease risk.

Latest News & Milestones:

• Levels secured a $10 million Series A, including $3 million in crowdfunding from over 2,000 investors to democratize glucose monitoring.

• Dr. Casey Means co-authored the #1 New York Times bestseller "Good Energy: The Surprising Connection between Metabolism and Limitless Health," which has been on the bestseller list for months

Dr. Andrea Maier

Co-Founder, Chi Longevity & Professor, NUS

Andrea blends research and practice, helping people adopt scientifically proven interventions for healthier aging through her Chi Longevity clinics.

She is a leading force in aging research, making longevity science accessible and cutting through the hype with evidence-based solutions. She champions personalized interventions based on your unique biomarkers, shifting the focus from generic supplements to targeted strategies that truly impact health and longevity.

Latest News & Milestones:

• Chi Longevity opened its second clinic at the Four Seasons Hotel Singapore, expanding its presence in Asia and marking a shift toward luxury, data-driven longevity treatments geared toward individuals seeking precision health solutions.

• She Co-hosted the Founders Longevity Forum addressing APAC’s aging challenges and reinforcing Singapore’s leadership in geroscience.

Dr. Evelyne Bischof

Physician-Scientist, President at Healthy Longevity Medicine Society

Evelyne is championing AI-driven longevity medicine, setting standards for predictive diagnostics and precision longevity therapies worldwide. She also directs the Longevity Department at the renowned Sheba Medical Center in Israel, integrating geroscience into hospital practice.

Her work is unique. It’s not just about one discovery. It’s about building an entire ecosystem: educating doctors, setting clinical guidelines, and ensuring that longevity breakthroughs actually reach patients.

Latest News & Milestones:

• Dr. Evelyne was appointed President of the Healthy Longevity Medicine Society (HLMS), she launched a global initiative to standardize AI-powered biomarkers and clinical protocols for longevity.

• She played a significant role in the 2024 Longevity Investors Conference in Davos, Switzerland, participating in multiple panels on topics such as "Latest Developments in Longevity and AI" and "A Roadmap to Sustainable Health and Better Wellbeing in the Workforce and Society"

• Continues her role as Medical Director of the Sheba Longevity Center at Sheba Medical Center, affiliated with Tel Aviv University, while also serving as a professor at Shanghai University of Medicine and Health Sciences

Nabiha Saklayen

Co-Founder, Cellino

Nabiha Saklayen is using laser-based technology to revolutionize stem cell therapies, making regenerative medicine more precise and scalable.

Her work is paving the way for affordable, accessible regenerative medicine, bringing cutting-edge cell therapies closer to those who need them. This could mean a future where treating chronic diseases is faster, more effective, and within reach for more people.

Latest News & Milestones:

• Cellino just announced a partnership with Matricelf to scale iPSC-based spinal cord injury therapies.

• Cellino launched The Foundry; the first AI-powered hospital-based iPSC manufacturing facility. Advancing their goal of making patient-specific stem cell-derived therapies available for broad patient audiences

• Cellino was awarded $25M in funding from the ARPA-H, to drive the development of their biomanufacturing technology for personalized regenerative medicine.

Anastasia Georgievskaya

CEO, Haut.AI

Anastasia Georgievskaya is transforming skincare with AI-driven solutions that personalize beauty and longevity interventions, making cutting-edge technology accessible.

Her AI-driven approach to skincare helps you understand your skin’s unique needs, using data to predict and prevent aging signs before they appear. By combining science and technology, she’s making smarter skincare choices effortless.

Latest News & Milestones:

• Haut.AI’s commercially launched SkinGPT, generative AI platform that simulates the effects of skincare products and treatments, revolutionizing virtual skincare try-ons for beauty brands.

• They introduced "Generative Skin: Library of Ingredient Effects," an interactive website allowing users to visualize the impact of various skincare ingredients on their skin through AI-generated simulations

• Haut.AI was granted a United States patent for its Skin Atlas system, which provides detailed skin analysis and personalized skincare recommendations while ensuring user privacy through advanced anonymization techniques

Carolina Reis & Alessandra Zonari

Co-Founders, OneSkin

This duo is redefining skincare by targeting the root causes of aging at the cellular level through pioneering longevity-focused topical treatments.

They’re proving that longevity science isn’t just for the future—it’s for your skin today. By using peptide technology to slow cellular aging, they help you maintain healthier, more resilient skin for the long run.

Latest News & Milestones:

• Their patented Peptide OS-01 has been scientifically proven to reverse skin's biological age by preventing the accumulation of senescent cells, positioning OneSkin as a leader in science-led topical skin longevity treatments

• OneSkin secured a $20 million Series A funding round, with Unilever Ventures among its key investors, signaling potential industry collaborations.

• OneSkin was recognized by Fast Company as one of 2024’s Most Innovative Companies, OneSkin is expanding its product line to further integrate molecular-level skin health solutions.

Dr. Elisabeth Roider

Partner & CSO, Maximon

Dr. Elisabeth Roider is a physician-scientist specializing in longevity biotech. She is the Chief Scientific and Medical Officer at Maximon AG, where she helps startups develop innovative solutions for healthy aging. She also works at University Hospital Basel and Harvard Medical School, contributing to advanced research in aging and regenerative medicine.

Her work bridges science and innovation, bringing breakthroughs breakthroughs in longevity into real-world solutions that may slow aging and improve quality of life.

Latest News & Milestones:

• Ayun Longevity Clinic launched in Zürich under Elisabeth’s leadership, offering advanced diagnostics and personalized treatments.

• She oversaw the launch of a CHF 100 million Longevity Co-Investment Fund, supporting startups focused on aging interventions and longevity biotech.

• She joined Maximon's leadership team as Partner and Chief Scientific and Medical Officer in 2022, bringing her expertise as a Harvard- and Swiss-trained physician-scientist to drive innovation in the longevity field

Dr. Alexandra Bause

Co-Founder & Partner, Apollo Health Ventures

Alexandra is shaping the future of longevity biotech as a Co-Founder and Partner at Apollo Health Ventures, a leading venture capital firm funding cutting-edge companies developing therapies to extend human healthspan.

Her vision ensures that longevity research transitions from the lab to transformative therapies. She focuses on high-impact investments and supports biotech startups from early-stage research to commercialization.

Latest News & Milestones:

• Apollo Health Ventures' portfolio company, Auron Therapeutics, Inc., recently received FDA approval for their investigational drug AUTX-703 and raised $27M in Series B funding to initiate Phase 1 trials in hematologic malignancies.

• Refoxy Pharma, successfully raised €9.1M in a seed-extension financing round to accelerate the preclinical development of novel FOXO3 activators targeting idiopathic pulmonary fibrosis

• Apollo-backed Ochre Bio secured a $1 billion deal with Boehringer Ingelheim for AI-driven liver disease therapeutics.

These women are not only shaping the future of longevity, they’re making it personal. Their work is turning aging into an opportunity to thrive.

As we follow their journeys, one thing is clear: the longevity revolution is powered by passion, innovation, and a belief that every stage of life can be lived to its fullest.

Imagine starting your day by looking into a mirror that not only shows your reflection but also provides a complete health assessment. Withings, a leader in connected health devices, is bringing this idea closer to reality with their latest concept unveiled at the CES 2025: the OMNIA AI-powered smart mirror for at-home health assessments.

A New Era of Health Tracking

OMNIA transforms an everyday morning routine into an intelligent health hub that seamlessly integrates with the Withings ecosystem, from smart scales, blood pressure monitors, and sleep analyzers, providing a daily view of your health.

What Makes OMNIA a Game-Changer?

• Health Metrics made Personal

OMNIA tracks over 60 health indicators, including heart health, body composition, sleep quality, skin hydration, and activity levels.

• AI That Speaks Your Language

A built-in AI assistant analyzes your data and gives you meaningful advice. It might suggest a high-protein breakfast after a poor night’s sleep or recommend stretching to ease tension. It’s practical, actionable, and tailored to your life.

• At-Home Doctor’s Office

The concept envisions seamless connectivity with healthcare professionals, enabling virtual consultations and data sharing directly through the mirror.

Why This Matters

Health monitoring is often reactive. We go to the doctor only when something feels wrong. OMNIA flips this narrative. It turns daily habits into opportunities for proactive care, catching potential issues before they escalate.

Think about chronic conditions like heart disease or diabetes. Early detection and consistent monitoring are key to better outcomes. OMNIA’s vision makes these steps easy, integrating health insights into your routine without the hassle of appointments.

The Bigger Picture

OMNIA could empower more people to take charge of their health, but two key factors will determine its success:

• Accesibility

While the technology is impressive, cutting-edge technology often comes at a high cost. Its impact depends on affordability and widespread adoption.

• Privacy

A mirror that collects personal health data must ensure that this information remains secure and confidential. Without strong data protection, gaining user trust will be difficult.

A Glimpse into The Future

Still in its concept phase, OMNIA represents a shift toward interconnected health ecosystems, where technology doesn’t just track your health but actively helps you improve it. This is a vision where health becomes a seamless part of daily life, something you live with, learn from, and continuously enhance.

On a Larger Scale…

OMNIA hints at how anonymized data could transform public health. By identifying trends and predicting outbreaks, it has the potential to optimize healthcare systems and benefit entire communities.

Living with Health

OMNIA highlights how health technology can blend effortlessly into our daily routines, turning simple habits into opportunities for better well-being. It’s about more than gadgets; it’s about empowering people to understand themselves and live healthier, every single day.

The upcoming opening of the Sand Clinic in Stockholm, founded by Anna Levander and Jennie Sandqvist, is just around the corner. Inspired and backed by a joint €4m investment from Spotify founders Daniel Ek and Martin Lorentzon, this clinic promises a new era of science-backed treatments and innovations in the heart of the Forskaren Science Center.

Key Innovations

• Personalized Plans: Members of the Sand Clinic can expect comprehensive health services customized to their unique individual needs.

• Data-Driven Platform: Seamlessly integrating cutting-edge technology to enable precise diagnostics and continuous monitoring, facilitating a comprehensive approach to healthcare. Connecting the dots for a more informed and personalized patient experience.

• Advanced Diagnostics and Treatments: Sand Clinic will offer a range of services to assess health risks, prevent diseases, and promote overall well-being. Providing cutting-edge treatments like vascular ultrasound, blood samples, heart and muscle performance checks, vacuum therapy, and red light therapy.

• Evidence-Based Care: By prioritizing science-backed treatments over unproven remedies commonly found in the wellness industry, Sand Clinic upholds a commitment to providing safe, effective, and evidence-based healthcare solutions.

• State-of-the-art facilities located at the Forskaren Science Center: Sand Clinic will be located within the Forskaren Science Center, a hub for life science innovation in the heart of Stockholm. This center is designed to foster collaboration and growth among businesses and researchers in the life sciences sector.

Tesla's Business Model Influence

Drawing inspiration from Tesla's business model, Anna Levander and Jennie Sandqvist are committed to enhancing accessibility to their services. Despite initial monthly fees ranging from €1K to €10K, the duo aims to broaden access by implementing a strategy akin to Tesla's approach:

“Our ambition is, over time, to open up smaller and less costly clinics with the most impactful treatments that we find from our collected data and the procedures we do here.”

Sifted Reports

Longevity on the Rise

The investment from high-profile entrepreneurs highlights the growth potential of the health and biotech sector. With the longevity market expanding into a billion-dollar industry, we witness increasing investor interest in supporting clinics. Daniel Ek's involvement in healthcare is not new; he also co-founded Neko Health, a diagnostics startup specializing in full-body scanning services, securing €60 million in Series A funding through a round led by Lakestar, with participation from Atomico and General Catalyst.

Resources

• Inspired by the insights featured in Sifted’s edition: Exclusive: Daniel Ek's new bet on longevity

• Spotify founders back new Swedish longevity clinic by. Longevity Technology

Insilico Medicine, not only has pioneered the first fully discovered and developed AI drug, but has just been named The #1 Biotech Company in Fast Company's 2024 World's Most Innovative Companies list. This recognition comes amidst a year of groundbreaking achievements, including the publication of their lead drug's story in Nature Biotechnology.

One of the most significant accomplishments is the development of the first drug entirely discovered and designed by artificial intelligence, currently in phase 2 human clinical trials as part of Insilico Medicine's groundbreaking TNIK program. This achievement represents a significant milestone in drug discovery, showcasing the power of AI in accelerating the development of novel therapeutics.

Insilico Medicine's TNIK program has successfully identified and designed a novel molecule for treating fibrotic diseases within an impressive timeframe of just 18 months, from target discovery to preclinical candidate nomination, significantly reducing both time and costs compared to traditional pharma.

Here's why this achievement is a big deal:

• Precision, Speed, and Cost-Effectiveness: The integration of generative AI in drug discovery enhances precision, accelerates development timelines, and reduces costs significantly.

• Tailored Therapeutic Solutions: AI enables the creation of personalized treatment options tailored to individual patient needs through data-driven insights.

• End-to-End AI-Driven Drug Discovery Platform: Insilico Medicine's TNIK program demonstrates the power of a complete AI-driven system for discovering and developing drugs. This approach utilizes Insilico Medicine's advanced end-to-end pipeline, incorporating platforms like PandaOmics for target discovery and Chemistry42 for drug design.

The integration of advanced AI technologies in drug discovery signifies a future where transformative therapies can be developed rapidly and with exceptional accuracy. Insilico Medicine's AI-driven platforms mark a significant shift in how we discover and develop new drugs, offering potential benefits across diverse therapeutic areas.

As we move towards a new era of precision medicine and healthcare innovation, Insilico Medicine's achievements signal a future filled with groundbreaking solutions for global challenges. Alex Zhavoronkov, the founder and CEO of Insilico Medicine, anticipates that “these breakthroughs will go way beyond biotech”.

You can find the paper published in Nature Biotechnology and interact with the paper through their ChatPaperGPT

Resources

Read

• Generative Artificial Intelligence for Drug Discovery: How the First AI-Discovered and AI-designed Drug Progressed to Phase 2 Clinical Testing

• Data Repository for TNIK anti-fibrotic program

• The most innovative companies in biotech in 2024

Meet Liz Parrish, the founder and CEO of BioViva Science, a company at the forefront of developing cutting-edge gene therapies to combat biological aging.

Driven by a personal mission to revolutionize healthcare, Liz courageously became the first person to undergo experimental gene therapies, to demonstrate their safety and efficacy, and pave the way for quicker regulatory approvals, ensuring more patients can access life-changing treatments sooner.

She has received gene therapies targeting important processes like muscle mass, telomeres, and mitochondria.

- Follistatin Therapy increased her muscle size, uplifting her metabolic health.

- Telomerase Therapy lengthened her telomeres to those of a healthy 25-year-old.

- Klotho improved her inflammation and blood sugar markers.

- PGC-1α No individual effects were mentioned, but it aims to reduce oxidative stress and boost mitochondria for increased energy in cells

The good news

• No Adverse Effects: Remarkably, none of the therapies has led to any negative side effects until now.

• Potential Impact: By addressing aging at the genetic level, these therapies hold promise in treating a spectrum of age-related diseases and conditions, offering hope for a healthier and more vibrant future.

While the field of genetic interventions is still evolving, the strides made by pioneers like Liz Parrish pave the way for a new era in personalized genetic interventions.

Resources

• Inspired by the insights featured in: The World’s Most Genetically Modified Person - Authored by Adam Alonzi and Ryan Hall

Disclaimers

• It is essential to consult healthcare professionals before considering any experimental gene therapies.

• The efficacy and safety of gene therapies may vary among individuals, emphasizing the need for thorough research and clinical oversight.

• The information provided is for educational purposes and does not constitute medical advice.

As my grandmother approaches her 101st birthday next week, I couldn't help but imagine reaching that milestone myself one day. This got me thinking about how much our genes influence living long, healthy lives, and I've realized that we have more control over our lifespan than we might realize.

We've all heard that certain traits run in families, right? Things like eye color or height are passed down from parent to child. Many of us also assume the same applies to longevity – if your grandparents lived to be 101, you must have inherited "good longevity genes" too.

This idea isn't entirely off the mark. Dr. Nir Barzilai's groundbreaking research provides insights into how our genes affect aging and overall health. Although his studies reveal that our genetic makeup significantly impacts both how we age and our overall healthspan, he emphasizes that while genetics matter, lifestyle factors are just as important.

A study conducted by Calico Labs challenges our assumptions about genetics and lifespan. Scientists analyzed hundreds of family histories and found evidence that relatives tend to live similar lengths of time. But then they noticed something interesting – husbands and wives also often had very similar lifespans, even though they were not biologically related.

This led researchers to realize an important factor; a phenomenon known as Assortative Mating. Essentially, we tend to choose partners who are similar to us, not just in personality and behavior, but also in physical appearance, education, socioeconomic status, and even some genetic factors. So couples end up sharing not just a life together, but also an entire lifestyle and environment. When researchers accounted for the effect of couples influencing each other, they found that genetics only accounts for 7% of how long we live, which is quite different from the previously estimated value of 20% to 30%.

I found this surprising because I have always assumed that if my grandparents lived to be 100, I must have inherited good longevity genes too. While genetics certainly play a role, it seems that the happy, healthy lifestyle and environment they cultivated for decades were also crucial factors in their long lives. My grandma, for instance, doesn't smoke, eats healthy, and stresses little, which is most probably contributing to her well-being. However, she didn't prioritize regular exercise throughout her life. I can't help but wonder how much more optimized her health could have been if physical activity had been a part of her routine.

So, next time someone celebrates their 101st birthday, remember that it's not just about our genes. Our lifespan is significantly shaped by the environment and lifestyle choices we make. Focusing on things like diet, exercise, sleep, low stress, and strong relationships remains the best way to promote longevity until we have more advanced rejuvenation therapies.

Resources:

• Estimates of the Heritability of Human Longevity Are Substantially Inflated due to Assortative Mating

• A study in human genetics demonstrates limited influence on longevity - Calico

• The Latest Updates in Longevity Research with Dr. Eric Verdin - Longevity by Design. Inside Tracker

• Genetic influence on human lifespan and longevity

We often accept pain and illness as inevitable parts of aging, but I believe we have the power to change that.

Taking control of our health

For me, it all begins with prevention and optimization. Why wait for sickness to happen when we can take proactive steps today to protect our future health? I’ve learned that we have more control over our well-being than we think.

Did you know that genetics only determine about 7% of how long and healthy we live? The remaining 93% is influenced by our daily choices—what we eat, how we move, our environment, and how we manage stress. These factors can help us stay active and vibrant, regardless of what our genes say.

The science of longevity is here

But lifestyle alone isn’t enough. There’s an exciting world of longevity science unfolding right now. Advances in CRISPR technology, genomics, AI, and other innovations are pushing the boundaries of what’s possible. We’re on the brink of transforming how we age, and I truly believe, this is only the beginning.

The first step: How I’m bringing my longevity passion to life

Five years ago, my curiosity about longevity turned into a personal mission. I wanted to understand how we could live healthier, longer lives. That’s how biocompass was born. It’s my way of bringing together everything I’ve learned about longevity science, health solutions, and the best ways to stay at our peak—so that you can take control of your own journey.

biocompass is a curated collection of the latest breakthroughs in health-tech and longevity. Bringing together products, experts, and leading wellness centers to help you navigate the overwhelming world of consumer health. The mission is simple: to empower you to take control of your health and longevity without feeling lost in the noise.

Join the movement

I believe the future of aging will look entirely different—where growing older isn’t about decline but about living vibrantly at every stage of life. And you can be a part of that transformation.

Subscribe to the newsletter to stay ahead of the curve. Every week, we’ll dive into the latest breakthroughs in longevity, wellness, and optimization—giving you the tools to live your best life for years to come. Let's navigate the future of health together!

Subscribe now